Hyperbaric oxygen treatment induces platelet aggregation and protein release, without altering expression of activation molecules

Clinical Biochemistry

Volumn 42, Issue 6, 2009, Pages 467-476

  Shaw, Frances L ^a   Winyard, Paul G ^a   Smerdon, Gary R ^b   Bryson, Philip J ^b   Moody, A John ^c   Eggleton, Paul ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b Tamar Science Park   (United Kingdom)

^c UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

2 D PAGE; Aggregation; Flow cytometry; Hyperbaric oxygen; Mass spectrometry; Nitric oxide; Platelets; Pressure

Indexed keywords

14 3 3 PROTEIN ZETA; ALPHA 2 MACROGLOBULIN; AMITROLE; BIOLOGICAL MARKER; CD31 ANTIGEN; MACROGLOBULIN; MEMBRANE PROTEIN; NITRIC OXIDE; OXYGEN; PADGEM PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERBARIC OXYGEN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

14-3-3 PROTEINS; ALPHA-MACROGLOBULINS; ANTIGENS, CD31; BLOOD PLATELETS; BLOOD PROTEINS; HUMANS; HYPERBARIC OXYGENATION; MEMBRANE GLYCOPROTEINS; NITRATES; NITRIC OXIDE; NITRITES; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET-RICH PLASMA;

EID: 61849126810     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.12.024     Document Type: Article

References (50)

1. Brown S.D., and Piantadosi C.A. Reversal of carbon monoxide-cytochrome c oxidase binding by hyperbaric oxygen in vivo. Adv. Exp. Med. Biol. 248 (1989) 747-754
2. Thom S.R. Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol. Appl. Pharmacol. 123 (1993) 248-256
3. Hampson N.B. Hyperbaric oxygen therapy: Committee Report (1989), Undersea and Hyperbaric Medical Society, Bethesda, Maryland
4. Knighton D.R., Silver I.A., and Hunt T.K. Regulation of wound-healing angiogenesis - effect of oxygen gradients and inspired oxygen concentration. Surg 90 (1981) 262-269
5. Hunt T.K., Linsey M., Grislis H., Sonne M., and Jawetz E. The effect of differing ambient oxygen tensions on wound infection. Ann. Surg. 181 (1975) 35-39
6. Hohn D.C., MacKay R.D., Halliday B., and Hunt T.K. Effect of oxygen tension on microbicidal function of leukocytes in wounds and in vitro. Surg. Forum 27 (1976) 18-20
7. Buras J.A., Stahl G.L., Svoboda K.K., and Reenstra W.R. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am. J. Physiol., Cell Physiol. 278 (2000) C292-C302
8. Shinomiya N., Suzuki S., Hashimoto A., Ito M., Takaai Y., and Oiwa H. Effect of hyperbaric oxygen on intercellular adhesion molecule-1 (ICAM-1) expression in murine lung. Aviat. Space Environ. Med. 69 (1998) 1-7
9. Pitchford S.C., Yano H., Lever R., et al. Platelets are essential for leukocyte recruitment in allergic inflammation. J. Allergy Clin. Immunol. 112 (2003) 109-118
10. Kuijper P.H., Gallardo Torres H.I., van der Linden J.A., et al. Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions. Blood 87 (1996) 3271-3281
11. Amin H.M., Hakim T.S., and Camporesi E.M. Hematological alterations after acute exposure to hyperbaric oxygen in rats. Clin. Exp. Pharmacol. Physiol. 22 (1995) 21-27
12. Labrouche S., Javorschi S., Leroy D., Gbikpi-Benissan G., and Freyburger G. Influence of hyperbaric oxygen on leukocyte functions and haemostasis in normal volunteer divers. Thromb. Res. 96 (1999) 309-315
13. Ersoz G., Ocakcioglu B., Bastug M., Ficicilar H., and Yavuzer S. Platelet aggregation and release function in hyperbaric oxygenation. Undersea Hyperb. Med. 25 (1998) 229-232
14. Thom S.R., Fisher D., and Stubbs J.M. Platelet function in humans is not altered by hyperbaric oxygen therapy. Undersea Hyperb. Med. 33 (2006) 81-83
15. Price R.A., Ogston D., and MacDonald A.G. Effects of high pressure on platelet aggregation in vitro. Undersea Biomed. Res. 13 (1986) 63-75
16. Klausen H., Hjelle J.O., Flood P.R., and Holmsen H. Morphological changes of blood platelets in man during deep saturation diving. Proc. 13th Meeting Eur. Undersea Biomed. Soc. (1987) 336-343
17. Murayama M. Ex vivo human platelet aggregation induced by decompression during reduced barometric pressure, hydrostatic, and hydroynamic (Bernoulli) effect. Thromb. Res. 33 (1984) 477-485
18. Granowitz E.V., Skulsky E.J., Benson R.M., et al. Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea Hyperb. Med. 29 (2002) 216-225
19. Benson R.M., Minter L.M., Osborne B.A., and Granowitz E.V. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin. Exp. Immunol. 134 (2003) 57-62
20. Vlodavsky E., Palzur E., and Soustiel J.F. Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury. Neuropathol. Appl. Neurobiol. 32 (2006) 40-50
21. Lin S., Shyu K.G., Lee C.C., et al. Hyperbaric oxygen selectively induces angiopoietin-2 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 296 (2002) 710-715
22. Kim K.E., Cho C.H., Kim H.Z., Baluk P., McDonald D.M., and Koh G.Y. In vivo actions of angiopoietins on quiescent and remodeling blood and lymphatic vessels in mouse airways and skin. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 564-570
23. Kang T.S., Gorti G.K., Quan S.Y., Ho M., and Koch R.J. Effect of hyperbaric oxygen on the growth factor profile of fibroblasts. Arch. Facial Plast. Surg. 6 (2004) 31-35
24. Thom S.R., Fisher D., Zhang J., et al. Stimulation of perivascular nitric oxide synthesis by oxygen. Am. J. Phys. 284 (2003) H1230-H1239
25. Huang T.Y., Tsai P.S., Wang T.Y., Huang C.L., and Huang C.J. Hyperbaric oxygen attenuation of lipopolysaccharide-induced acute lung injury involves heme oxygenase-1. Acta Anaesthesiol. Scand. 49 (2005) 1293-1301
26. Fraga-Silva R.A., Pinheiro S.V.B., Goncalves A.C.C., Alenina N., Bader M., and Santos R.A.S. The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets. Mol. Med. 14 (2008) 28-35
27. Arnold W.P., Mittal C.K., Katsuki S., and Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. U. S. A. 74 (1977) 3203-3207
28. Mellion B.T., Ignarro L.J., Ohlstein E.H., Pontecorvo E.G., Hyman A.L., and Kadowitz P.J. Evidence for the inhibitory role of guanosine 3′, 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57 (1981) 946-955
29. Radomski M.W., Palmer R.M., and Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 148 (1987) 1482-1489
30. Freedman J.E., Loscalzo J., Barnard M.R., Alpert C., Keaney J.F., and Michelson A.D. Nitric oxide released from activated platelets inhibits platelet recruitment. J. Clin. Invest. 100 (1997) 350-356
31. Li Z., Ajdic J., Eigenthaler M., and Du X. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans. Blood 101 (2003) 4423-4429
32. Li Z., Zhang G., Marjanovic J.A., Ruan C., and Du X. A platelet secretion pathway mediated by cGMP-dependent protein kinase. J. Biol. Chem. 279 (2004) 42469-42475
33. Radomski M., and Moncada S. An improved method for washing of human platelets with prostacyclin. Thromb. Res. 30 (1983) 383-389
34. Moody A.J., and Shaw F.L. Reevaluation of the Griess reaction: how much of a problem is interference by nicotinamide nucleotides?. Anal. Biochem. 356 (2006) 154-156
35. Higuchi K., and Motomizu S. Flow-injection spectrophotometric determination of nitrite and nitrate in biological samples. Anal. Sci. 15 (1999) 129-134
36. Hempling H.G. Permeability of the Ehrlich ascites tumor cell to water. J. Gen. Physiol. 44 (1959) 365-379
37. Handy R.D., Bryson P., Moody A.J., Handy L.M., and Sneyd J.R. Oxidative metabolism in platelets, platelet aggregation, and hematology in patients undergoing multiple hyperbaric oxygen exposures. Undersea Hyperb. Med. 32 (2005) 327-340
38. Coppinger J.A., Cagney G., Toomey S., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103 (2004) 2096-2104
39. Pula G., Schuh K., Nakayama K., Nakayama K.I., Walter U., and Poole A.W. PKCdelta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation. Blood 108 (2006) 4035-4044
40. Du X., Harris S.J., Tetaz T.J., Ginsberg M.H., and Berndt M.C. Association of a phospholipase A2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex. J. Biol. Chem. 269 (1994) 18287-18290
41. Dai K., Bodnar R., Berndt M.C., and Du X. A critical role for 14-3-3zeta protein in regulating the VWF binding function of platelet glycoprotein Ib-IX and its therapeutic implications. Blood 106 (2005) 1975-1981
42. Harrison P., and Cramer E.M. Platelet alpha-granules. Blood Rev. 7 (1993) 52-62
43. Grinnell F., and Zhu M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J. Invest. Dermatol. 106 (1996) 335-341
44. Trengove N.J., Stacey M.C., MacAuley S., et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 7 (1999) 442-452
45. Chen S.M., Ward S.I., Olutoye O.O., Diegelmann R.F., and Kelman Cohen I. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair Regen. 5 (1997) 23-32
46. Alleva R., Tomasetti M., Sartini D., et al. Alpha-lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy. Mol. Med. 14 (2008) 175-183
47. Winyard P.G., Hider R.C., Brailsford S., Drake A.F., Lunec J., and Blake D.R. Effects of oxidative stress on some physicochemical properties of caeruloplasmin. Biochem. J. 258 (1989) 435-445
48. Wachowicz B., Krajewski T., and Zbikowska H. Protective effect of ceruloplasmin against lipid peroxidation in blood platelets. Acta Biochim. Pol. 37 (1990) 261-266
49. Crane M.S., Rossi A.G., and Megson I.L. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations. Br. J. Pharmacol. 144 (2005) 849-859
50. Inoue K., Akaike T., Miyamoto Y., et al. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J. Biol. Chem. 274 (1999) 27069-27075